Sarah Mitchell spent three years unable to leave her home. Her skin wept constantly, cracked and bled at the slightest movement, and burned with an intensity she describes as "worse than childbirth." She had used steroid creams for eczema since childhood. When she stopped, her skin erupted.

Mitchell is one of hundreds who have reached out to the BBC describing similar ordeals—a constellation of severe symptoms they believe stems from stopping topical steroid medications. But the medical establishment remains fractured over a fundamental question: does the condition they're describing actually exist?

The controversy centers on Topical Steroid Withdrawal (TSW), also called Red Skin Syndrome—a proposed condition that some patients and physicians say occurs when people stop using corticosteroid creams after prolonged use. Sufferers report skin that becomes red, inflamed, and extraordinarily sensitive, sometimes across the entire body. The symptoms can persist for months or years.

A Medical Divide With Real Consequences

According to reporting by BBC News, the medical community is locked in disagreement. Some dermatologists maintain that what patients call TSW is actually a rebound flare of the underlying eczema or dermatitis that was being treated in the first place. They argue that stopping effective medication naturally leads to worsening symptoms.

Others, however, have begun recognizing TSW as a distinct phenomenon—one potentially triggered by the skin becoming dependent on steroid creams, particularly when used frequently or on sensitive areas like the face. These physicians point to the severity and duration of symptoms that seem disproportionate to the original condition.

The debate leaves patients in an impossible position. Without consensus on diagnosis, there's no agreed-upon treatment protocol. Some dermatologists recommend resuming steroid use; others suggest enduring the symptoms until the skin "resets." For patients like Mitchell, this uncertainty extends their suffering.

"I was told by one doctor it was all in my head," Mitchell told the BBC. "Another said I should never have stopped the steroids. A third said I needed to stay off them completely. I didn't know who to believe while my skin was falling apart."

The Scale of Suffering

The volume of responses to the BBC's reporting suggests the issue is more widespread than many in the medical community may realize. Patients describe becoming housebound, unable to work, and experiencing profound psychological distress alongside physical symptoms.

Many report that their skin becomes hypersensitive to temperature changes, water, and even air. Some say they've lost jobs, relationships, and years of their lives to a condition that doesn't appear in many medical textbooks.

Online support groups for TSW have grown substantially in recent years, with thousands of members sharing photographs of their skin and timelines of their recovery—or lack thereof. These communities have become crucial sources of information and emotional support for people who feel abandoned by conventional medicine.

The Science Behind the Controversy

Topical corticosteroids have been a cornerstone of dermatological treatment for decades. They reduce inflammation effectively and are generally considered safe when used as directed. The controversy arises over what happens with long-term use and subsequent discontinuation.

Some research has documented changes in skin structure with prolonged steroid application, including thinning and altered barrier function. A smaller body of literature describes rebound phenomena when treatment stops. However, large-scale studies specifically examining TSW remain limited, contributing to the medical divide.

Critics of the TSW diagnosis argue that the lack of robust clinical trials and standardized diagnostic criteria makes it difficult to distinguish from other conditions. They worry that patients are being encouraged to avoid effective treatments based on anecdotal evidence.

Proponents counter that the absence of research doesn't mean the condition doesn't exist—it means it's been understudied. They point to the consistent pattern of symptoms across patient reports and the timeline of recovery that many document.

A Call for Research and Recognition

The situation highlights a broader challenge in medicine: what happens when patient experiences outpace medical understanding? The hundreds who contacted the BBC aren't seeking validation for its own sake—they're desperate for effective treatment and medical support.

Several patient advocacy groups are now pushing for formal research into TSW, including studies that could establish diagnostic criteria and identify which patients might be at highest risk. Some are calling for clearer guidelines on steroid cream prescribing, particularly regarding duration of use and tapering protocols.

Dr. Marjorie Lazoff, a dermatologist based in California who has studied steroid-related skin reactions, told medical publications last year that the phenomenon deserves serious investigation. "Whether we call it TSW or rebound dermatitis, we're seeing patients with severe, prolonged symptoms after stopping topical steroids. We owe it to them to understand what's happening."

For now, patients remain caught between competing medical opinions, often forced to become their own researchers and advocates. Mitchell eventually found a physician willing to support her through what she believes was TSW. After two years of careful skin management without steroids, her symptoms gradually subsided.

"I got my life back," she said. "But I lost three years first. How many others are going through this right now with nowhere to turn?"

The question hangs over a medical debate that, for those suffering, is anything but academic. Until the profession reaches consensus, hundreds—perhaps thousands—will continue navigating their condition in the dark, trapped between doctors who can't agree on whether their suffering is even real.